Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

LivaNova to Present at the Stifel 2019 Healthcare Conference


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference on Wednesday, November 20 in New York at 3 p.m. Eastern Time.

The discussion will be available to all interested parties through a live audiocast accessible via the Investor Relations section of the LivaNova website at www.livanova.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. Replays of the webcast will be available on the LivaNova website within 24 hours after the live presentation for 90 days after the event.

About LivaNova

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide. LivaNova operates as two businesses: Cardiovascular and Neuromodulation, with operating headquarters in Mirandola (Italy) and Houston (U.S.), respectively.

For more information, please visit www.livanova.com.

Safe Harbor Statement

This news release contains "forward-looking statements" concerning our goals, beliefs, expectations, strategies, objectives, plans and underlying assumptions and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding participation in an upcoming event. Actual results may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2018, as supplemented by any risk factors contained in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K. We undertake no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.


These press releases may also interest you

at 11:40
BiaTech Corporation today announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements. BiaTech is focused on AI-enabled edge and cloud technology for clean energy and utility...

at 11:32
Demandbase, the leader in AI-driven account-based go-to-market (GTM), today announced that it has not only been recognized as a leader in numerous G2 Spring Reports, it has also achieved a highly coveted placement on G2's Best Marketing & Digital...

at 11:25
The "Consumer Brain-Computer Interface: Market and Product Development Trends" report has been added to ResearchAndMarkets.com's offering. Over the past decade, brain-computer interface (BCI) technology has expanded beyond the confines of the...

at 11:25
Caravelle International Group , a global ocean technology company, today announced that it received a notice from The Nasdaq Stock Market LLC indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the fiscal year...

at 11:19
On 29 March 2024, BTR New Material Group Co., Ltd. ("BTR")(835185.BJ), a global leader in battery materials, inked an investment agreement with the Moroccan government to erect a lithium battery ternary cathode material facility in the country. The...

at 11:13
Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. (Laborie)?announced its investment in iO Urology, a venture-backed medical technology company that developed CarePath® an at-home, handheld uroflow...



News published on and distributed by: